We’re proud to share that Clario’s Bangalore office has received the India Workplace Equality Index (IWEI) Bronze Award for Top Employer for LGBT+ Inclusion! ?? ?? This recognition highlights our commitment to fostering an inclusive workplace where everyone feels valued and supported. The Bronze Award is given to organizations that have taken significant steps to promote LGBT+ inclusion through inclusive policies and initiatives. We're excited to continue our journey toward a more inclusive and diverse workplace for all. ? #IWEI2024 #EqualAtWork #Inclusion #TeamClario
Clario
生物技术研究
Philadelphia，Pennsylvania 107,074 位关注者
Transforming Lives by Unlocking Better Evidence | Decentralized clinical trials | Broadest endpoint technology
关于我们
Clario is a leading healthcare research and technology company that generates high quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported clinical trials over 26,000 times in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2019. For more information, visit Clario.com
- 网站
-
https://clario.com/
Clario的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Philadelphia，Pennsylvania
- 类型
- 私人持股
- 创立
- 1972
- 领域
- Cardiac Solutions、Medical Imaging、eCOA、Respiratory Solutions、Precision Motion、Specialty Solutions、Clinical Adjudication和Artificial Intelligence
地点
Clario员工
动态
-
Clario's Chief Medical Officer, Todd Rudo, M.D., was recently invited to participate in a Live Panel Discussion hosted by AliveCor. This engaging fireside chat will bring together leading experts to explore how advanced #ECG technologies and #AI are transforming clinical trials by enhancing data accuracy and operational efficiency. Register now to learn: ?? How AI-powered ECG technology is improving data collection and delivery. ?? Patient-centered solutions addressing cardiac safety challenges, data integrity, and compliance. ?? Insights into how these innovations align with #FDA guidance and the future of clinical trials. Don’t miss this opportunity to stay ahead in #ClinicalTrial advancements! ?? https://lnkd.in/d5Brhwip
-
-
The good news keeps rolling in from GeorgiaCIO! ?? Clario's Chief Information, Technology and Product Officer, Jay Ferro, joins our Chief Information Security Officer, Murtaza Nisar, as a winner of a 2024 #Orbie Award. ?? Jay was recognized in the Large Corporate category as a CIO who delivers: ?? Leadership and management effectiveness ?? Business value through technology innovation ?? Engagement in industry and numerous community endeavors Jay’s commitment to data protection and enthusiasm for developing technologies and products that transform lives is infectious. We at Clario are proud to have him as one of our leaders and are excited to see his achievements recognized by Georgia CIO! #ClarioPride
-
-
We are thrilled that Clario's Chief Information Security Officer, Murtaza Nisar, has been awarded a 2024 GeorgiaCISO #Orbie. ?? Murtaza has guided his team through a number of remarkable milestones since he arrived at Clario, including our recent ISO 27001:2022 certification. Anyone who has worked with him knows that his leadership transcends cybersecurity and positively impacts everyone at our company. We are delighted to see his work recognized outside of Clario. Congrats, Murtaza!??
-
-
Developing a Parkinson’s disease drug comes with important questions. Will it be safe and effective? Will it be free from significant side effects? ?? Our globally renowned scientific and medical teams are here to support you in building a robust development strategy tailored to answer your questions -- no matter where your drug is in its trial journey. ? Watch our on-demand webinar to learn how. https://lnkd.in/d9ts99XD #ClarioNeuroscience #ClinicalTrials #ParkinsonsDisease #DrugDevelopment
-
-
On this World COPD Day, we at Clario wish to remind everyone of the importance of this globally devastating disease and encourage all to #KnowYourLungFunction! According to the American Thoracic Society (ATS), COPD claims 3 million lives annually. Click this link to learn more from ATS about the importance of early screening for improving COPD outcomes. ? ?https://lnkd.in/dw4ciSn6 At Clario, we address COPD and other lung diseases by driving the innovation of digital solutions for clinical trial investigators and sponsors. ? To explore how we can support drug development for respiratory/pulmonary diseases, visit our Respiratory Solutions web page: ?https://lnkd.in/guvMDqe7 #Clario #RespiratorySolutions #WorldCOPDDay #COPD #respiratoryhealth
-
Are you attending the Clinical Outsourcing Group CRO Summit? Make sure to stop by the Clario booth! Our experts are excited to meet you and share the latest advancements that can help transform your #ClinicalTrials. Visit our website for more information and registration details. See you there! ?? ? https://lnkd.in/dM2ZjC3V
-
-
At Clario, we value the moments when our global teams have the opportunity to come together! ? Our team in Budapest recently welcomed Clario’s President & CEO, Christopher Fikry, M.D., for a special Meet & Greet session. He was joined by Terry Burke, EVP of our eCOA business, and George Ng, VP of eCOA Operations, who shared valuable insights and updates on our eCOA business. These sessions strengthen our collaboration and reflect our commitment to innovation and teamwork across continents. ?? #TeamClario #ClarioBudapest
Talent Acquisition Partner at Clario | Clinical Trials and Technology Opportunities
?? Honoring Our Esteemed Guests and Inspiring Collaborations! ?? We’re thrilled to share how productive and engaging our day was during our Wednesday's 11th Lunch & Learn Session Clario #Budapest! We were truly honored by the presence of our esteemed guests, who took time from their busy schedules to join us and share their expertise. A heartfelt THANK YOU to our guests and speakers for making this event not just informative, but also a testament to the value of connection and shared purpose. Gratitude Highlights: In the morning, we had the pleasure and honor of hosting a Meet & Greet session at the Clario #Budapest office with our President & CEO, Christopher Fikry, M.D. Later in the afternoon, during the Lunch & Learn, Terry Burke and George Ng, shared a comprehensive #eCOA Business Update, providing valuable perspectives and updates. A big shoutout to Anna Jánosity, PhD, Ieneke Toxopeus, Adrienn Krauszman, Anett Turoczi, who presented a thorough overview of eCOA #DataManagement and #DataCoordination—your expertise shone through! Lastly, Marko Bozic captivated us with fascinating insights into #Hematology #eCOA Solutions, rounding out an informative session. It’s always inspiring to see the depth of knowledge and collaboration within our teams. Thank you to everyone who participated and made this day a success! Let’s continue to learn, grow, and innovate together. ?? #Teamwork #LunchAndLearn #eCOA #Collaboration #KnowledgeSharing #ClarioBudapest Janos Toth Réka Amanda Szabó-Navrasics Eszter Roth Hunor Nagy Dalma Beke-Saliga Dora Siminszky Matthew Stedman Tünde Sztojov Nathalie Fischer Sebastian Braun
-
-
? If you missed our LinkedIn Live event last week, the recording is now available! Watch it now to catch up as our experts discussed the potential impact of Europe’s new AI Act on clinical trials, including: ? AI-related risk assessment ? Clario’s responsible AI development process ? Real-world use cases addressing the new EU AI Act #StayTuned for Clario's upcoming events! ??
?? Join our LinkedIn Live: "The European AI Act: Potential Implications for Clinical Trials" ?? On November 14 at 9 a.m. EST/3 p.m. CET, Clario’s SVP and General Counsel, Lauren Misztal, and our Chief AI Officer, Marko Topalovic, will explore the potential impact of Europe’s new AI Act on clinical trials. Additional topics will include: ? AI-related risk assessment considerations for clinical trials ? Steps in Clario’s responsible AI development and use process ? Real use cases that demonstrate how Clario is approaching compliance with the new EU AI Act ? Don’t miss the chance to ask questions and engage with our experts as they discuss Clario’s approach to EU AI Act compliance and the responsible use of AI. Save the date and join this interactive session! ??
The European AI Act: Potential Implications for Clinical Trials
www.dhirubhai.net